Navigation Links
Daiichi Sankyo and Forest Laboratories Finalize Contract for Co-Promotion of AZOR(TM)
Date:10/12/2007

full prescribing information for AZOR.

About Daiichi Sankyo, Inc.

Daiichi Sankyo, Inc., headquartered in Parsippany, New Jersey, is the U.S. subsidiary of Daiichi Sankyo Co., Ltd., Japan's second largest pharmaceutical company and a global leader in pharmaceutical innovation since 1899. The company is dedicated to the discovery, development and commercialization of innovative medicines that improve the lives of patients throughout the world.

The primary focus of Daiichi Sankyo's research and development is cardiovascular disease, including therapies for dyslipidemia, hypertension, diabetes, and acute coronary syndrome. The company is also pursuing the discovery of new medicines in the areas of glucose metabolic disorders, infectious diseases, cancer, bone and joint diseases, and immune disorders.

For more information, please visit http://www.dsus.com.

About Forest Laboratories and Its Products

Forest Laboratories (http://www.frx.com) is a US-based pharmaceutical company dedicated to identifying, developing and delivering products that make a positive difference in peoples' lives. Forest Laboratories' growing product line includes Lexapro(R) (escitalopram oxalate), an SSRI indicated for adults for the initial and maintenance treatment of major depressive disorder and generalized anxiety disorder; Namenda(R) (memantine HCl), an N-methyl D-aspartate (NMDA)-receptor antagonist indicated for the treatment of moderate to severe Alzheimer's disease; and Campral(R)* (acamprosate calcium), indicated in combination with psychosocial support for the maintenance of abstinence from alcohol in patients with alcohol dependence who are abstinent at treatment initiation. In addition to our growing product line, Forest also co-promotes the Daiichi Sankyo, Inc. products Benicar(R)* (olmesartan medoxomil), an angiotensin receptor blocker, and Benicar HCT(R)
'/>"/>

SOURCE Daiichi Sankyo, Inc.; Forest Laboratories
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce Positive Results of Phase III Study for Milnacipran as a Treatment for Fibromyalgia Syndrome
2. Columbia Laboratories Reports Positive Results from Multi-dose Pharmacokinetic Study of Vaginally-administered Lidocaine
3. Northfield Laboratories Reports Results of Pivotal Phase III Trauma Study
4. Northfield Laboratories Investor Update
5. Columbia Laboratories Reports Preliminary Findings from the Ongoing Data Analysis of the Phase III Clinical Study of PROCHIEVE 8% (progesterone gel) to Prevent Preterm Birth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... July 7, 2015 The Global ... million by 2020, growing at an estimated CAGR of 7.6% ... Grand View Research, Inc. Introduction of innovative technologies including hand ... awareness levels pertaining to the advantages of breast milk are ... years. In addition, presence of untapped growth opportunities in emerging ...
(Date:7/7/2015)... , July 7, 2015   InspireMD, Inc. ... a leader in embolic protection systems ("EPS"), today ... Protection System integrated with MicroNet ™ has ... Stent New Product Innovation Award.  Through active market ... analysts and consultants recognize the successful introduction of ...
(Date:7/7/2015)... , July 7, 2015 /PRNewswire/ -- Mindray Medical International ... developer, manufacturer and marketer of medical devices worldwide, ... remaining stake in Wuhan Dragonbio Surgical Implant Co., ... Dragonbio is a domestic medical orthopedic-product provider ... surgical products. Prior to today,s announcement, Mindray already ...
Breaking Medicine Technology:Breast Pumps Market To Reach $1,197.7 Million By 2020: Grand View Research, Inc. 2Breast Pumps Market To Reach $1,197.7 Million By 2020: Grand View Research, Inc. 3Breast Pumps Market To Reach $1,197.7 Million By 2020: Grand View Research, Inc. 4InspireMD Receives Frost & Sullivan 2015 European Coronary Stent New Product Innovation Award 2InspireMD Receives Frost & Sullivan 2015 European Coronary Stent New Product Innovation Award 3InspireMD Receives Frost & Sullivan 2015 European Coronary Stent New Product Innovation Award 4InspireMD Receives Frost & Sullivan 2015 European Coronary Stent New Product Innovation Award 5Mindray Medical to Acquire the Remaining Stake in Wuhan Dragonbio 2Mindray Medical to Acquire the Remaining Stake in Wuhan Dragonbio 3Mindray Medical to Acquire the Remaining Stake in Wuhan Dragonbio 4
... , AUSTIN, Texas, Sept. 14 WillWalk, ... forefront of ending Paralysis. WillWalk will raise $3 million to help fund ... Injury (SCI). , , The money raised will fund ... cells being used are a non-controversial adult stem cell from umbilical cord ...
... , SAN DIEGO, Sept. 13 NexBio, Inc. ... against H1N1 influenza and NAI-resistant influenza at the 2009 Interscience ... September 13, 2009, in San Francisco, CA. The work ... Disease Control and Prevention (CDC), University of Hong Kong, and ...
Cached Medicine Technology:Paralyzed Artist Launches WillWalk Foundation to Cure Paralysis with Breakthrough Stem Cell Research 2NexBio(R) Presents DAS181 (Fludase(R)*) Potently Inhibits Novel Swine-Origin A(H1N1) and NAI-Resistant Influenza Viruses, at ICAAC 2009 2NexBio(R) Presents DAS181 (Fludase(R)*) Potently Inhibits Novel Swine-Origin A(H1N1) and NAI-Resistant Influenza Viruses, at ICAAC 2009 3
(Date:7/6/2015)... ... July 06, 2015 , ... University of Pittsburgh Cancer Institute ... thyroid cancer testing to reflect newly available tests that better incorporate personalized medicine into ... to interpret thyroid cancer tests is published in the July issue of the scientific ...
(Date:7/6/2015)... ... ... 22, 2015, Fox News in a report titled “ Female Hair Loss Needs to be ... quarter of all women in the U.S. will suffer from thinning hair or hair loss ... One woman, a former beauty queen, who was interviewed for the report began losing her ...
(Date:7/6/2015)... (PRWEB) , ... July 06, 2015 , ... ... Practice & Medical Spa industries, announces the return of its complimentary educational ... team of aesthetic medical business leaders creates success for their clients through targeted ...
(Date:7/6/2015)... Virginia (PRWEB) , ... July 06, 2015 , ... ... choose fat-reduction procedures each year for aesthetic reasons, which is why liposuction regularly ... For a particular demographic, however, fat reduction has become more than a way ...
(Date:7/6/2015)... ... July 06, 2015 , ... Olive Fertility Centre is proud to announce that ... Award on behalf of the department of Family Practice. , “This award is a ... practicing in. The technology is changing so rapidly and we are also developing new ...
Breaking Medicine News(10 mins):Health News:Pitt Scientists Lead Consensus Guidelines for Thyroid Cancer Molecular Tests 2Health News:Pitt Scientists Lead Consensus Guidelines for Thyroid Cancer Molecular Tests 3Health News:Pitt Scientists Lead Consensus Guidelines for Thyroid Cancer Molecular Tests 4Health News:Pitt Scientists Lead Consensus Guidelines for Thyroid Cancer Molecular Tests 5Health News:The Stigma of Female Hair Loss and Hair Restoration Solutions 2Health News:Acara Partners Announces Complimentary Educational Webinar Series for Cosmetic Medical Practices and MedSpas 2Health News:Acara Partners Announces Complimentary Educational Webinar Series for Cosmetic Medical Practices and MedSpas 3Health News:Learn How CoolSculpting® and Liposuction in Virginia Beach Help Military Members Stay the Course 2Health News:Learn How CoolSculpting® and Liposuction in Virginia Beach Help Military Members Stay the Course 3Health News:Olive Fertility Centre Physician Honoured for Teaching 2
... boozing! In the current edition of Deutsches rzteblatt ... Martin Stolle et al. of the German Center for ... that the main change has been the increase in ... authors present motivating short-term interventions to counteract secondary problems. ...
... measured clinically by a simple method as a preoperative ... glomerular filtration rate (GFR). Recently, an equation for estimated ... eGFR has been accepted as equal to measured GFR ... previous studies regarding the reliability of eGFR as a ...
... Now, a CMMS application that you can personalize.PITTSBURGH, May ... , a leading provider of Computerized Maintenance Management Systems ... a CMMS you can personalize.This new product offering is ... organization,s business needs and business problems. Users can create ...
... Awareness Day (May 22) NEW YORK, May 22 ... new survey results reveal alarming gaps in the public,s awareness ... that affects three to five million Americans. In a ... to being "not at all knowledgeable" about gout and just ...
... May 22 /PRNewswire-FirstCall/ - AIM Health Group Inc. ("AIM" ... health care company, announced today that its income for ... increased to $271,835 from a loss of $32,194 in ... EBITDA(1) increased 170% to $672,303 from $248,810, on a ...
... and GQ Magazine Launch Public Service Campaign with Designer ... GEOFFREY BEENE GIVES BACK(R) and GQ Magazine ... like nine-time Grammy Award winner, Sheryl Crow, and some ... cancer, HIV-AIDS, heart disease, Alzheimer,s, genetics and personalized medicine ...
Cached Medicine News:Health News:A first choice of renal function tests in hepatectomy patients 2Health News:Four Rivers Software System Launches TMS OnSite Professional 2Health News:The Gout & Uric Acid Education Society (GUAES) Announces New Survey Results Highlighting Major Gaps in Public Awareness of Gout 2Health News:The Gout & Uric Acid Education Society (GUAES) Announces New Survey Results Highlighting Major Gaps in Public Awareness of Gout 3Health News:AIM Health Group Inc. reports largest quarterly profit since going public and announces filing of financial results for the three months ended March 31, 2009 on SEDAR 2Health News:AIM Health Group Inc. reports largest quarterly profit since going public and announces filing of financial results for the three months ended March 31, 2009 on SEDAR 3Health News:AIM Health Group Inc. reports largest quarterly profit since going public and announces filing of financial results for the three months ended March 31, 2009 on SEDAR 4Health News:Photos: The Nation's Leading Scientists and Top Rock Stars Shine a Spotlight on the Promise of Medical Research 2Health News:Photos: The Nation's Leading Scientists and Top Rock Stars Shine a Spotlight on the Promise of Medical Research 3Health News:Photos: The Nation's Leading Scientists and Top Rock Stars Shine a Spotlight on the Promise of Medical Research 4
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: